Clinical Report: Sugar-Sweetened Beverages May Raise Risk of Hepatic Cancer Subtypes

Overview

Higher consumption of sugar-sweetened beverages is associated with an increased risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Background

Hepatic cancer, particularly hepatocellular carcinoma (HCC), is a significant public health concern. This study investigates the relationship between sugar-sweetened and artificially-sweetened beverage intake and hepatic cancer risk.

Data Highlights

Key Findings

• Each additional daily sugar-sweetened beverage is associated with a 10% higher likelihood of HCC.
• Each additional daily sugar-sweetened beverage is associated with a 15% higher likelihood of ICC.
• Artificially-sweetened beverage intake is not associated with overall hepatic cancer risk.
• Subgroup analyses show consistent findings among participants with and without diabetes.
• Self-reported beverage consumption limits the assessment of changes over time.
• Most participants were from predominantly White populations, affecting generalizability.

Clinical Implications

Healthcare professionals should consider dietary intake of sugar-sweetened beverages when assessing liver cancer risk in patients. Further research may be needed to explore the long-term effects of beverage consumption on hepatic health.

Conclusion

The study reports a link between sugar-sweetened beverage consumption and specific hepatic cancer subtypes.

Related Resources & Content

1. JAMA Network Open, 2023 -- Sugar-Sweetened and Artificially Sweetened Beverages and Liver Cancer—A Hard Look at Soft Drinks
2. The ASCO Post, 2016 -- Increased Risk of Gallbladder Cancer May Be Associated With Consuming Large Amounts of Sweetened Beverages
3. JAMA Network Open, 2023 -- Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer
4. The ASCO Post, 2023 -- Does Daily Consumption of Sugar-Sweetened Beverages Increase the Risk of Liver Disease Among Postmenopausal Women?
5. EASL, 2024 -- New EASL Clinical Practice Guidelines on Hepatocellular Carcinoma
6. PMC, 2023 -- Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision
7. Nature Food, 2025 -- Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes
8. New EASL Clinical Practice Guidelines on Hepatocellular Carcinoma - EASL-The Home of Hepatology.
9. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision - PMC
10. Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes | Nature Food